Novel CMKLR1 Inhibitors for Application in Demyelinating Disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-43428-8.pdf
Reference36 articles.
1. Pelletier, D. & Hafler, D. A. Fingolimod for multiple sclerosis. N Engl J Med 366, 339–347, https://doi.org/10.1056/NEJMct1101691 (2012).
2. Steinman, L. Multiple sclerosis: a two-stage disease. Nat Immunol 2, 762–764 (2001).
3. Vargas, D. L. & Tyor, W. R. Update on disease-modifying therapies for multiple sclerosis. Journal of investigative medicine: the official publication of the American Federation for Clinical Research 65, 883–891, https://doi.org/10.1136/jim-2016-000339 (2017).
4. Zabel, B. A., Rott, A. & Butcher, E. C. Leukocyte chemoattractant receptors in human disease pathogenesis. Annual review of pathology 10, 51–81, https://doi.org/10.1146/annurev-pathol-012513-104640 (2015).
5. Baharnoori, M., Mahajan, R., Solomon, I. H., Pinkus, G. & Houtchens, M. Fingolimod-Associated Intracerebral Lymphoproliferative Disorder. American journal of therapeutics, https://doi.org/10.1097/MJT.0000000000000694 (2017).
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma;Cancer Research;2024-04-19
2. The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative Disorders;International Journal of Molecular Sciences;2023-11-18
3. Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies;Pharmacology & Therapeutics;2022-12
4. Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression;Frontiers in Pharmacology;2022-11-29
5. Chemokine-like receptor 1 plays a critical role in modulating the regenerative and contractile properties of muscle tissue;Frontiers in Physiology;2022-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3